2024-514318-11-00CompletedPhase 1
Pharmacokinetics of inhaled levosimendan: a pilot study
Source: EU CTIS (euclinicaltrials.eu) · Last updated 26 Jan 2026
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 6 (actual)
- First submitted
- 10 Sept 2024
- Start date
- 17 Jan 2024
- Lead sponsor
- UZ Brussel
- Diseases
- Heart failure
- EU CT number
- 2024-514318-11-00
- EudraCT number
- 2022-002628-11
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 6
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| UZ Brussel | Jette | Belgium | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.